<Disease><Name>DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME (DOORS)</Name><Synonym>DOOR SYNDROME</Synonym><OMIM><Number>220500</Number><URL>http://omim.org/entry/220500</URL></OMIM><Orphanet><Number>79500</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79500</URL></Orphanet><Protein><Number>TBC1 domain family member 24</Number><URL>http://www.uniprot.org/uniprot/Q9ULP9</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>16p13.3</Gene><ICD>Q87.8</ICD><Summary>rare;autosomal recessive;mutation in the TBC1D24 gene;2 types:;- organic acid abnormalities;- not accompanied with organic acid abnormalities</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1761</id><symptom>coarse facial features</symptom><category>HEAD</category></symtomp><symtomp><id>1720</id><symptom>congenital heart defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3228</id><symptom>dermatoglyphic abnormalities</symptom><category>SKIN</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2214</id><symptom>hyporeflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2325</id><symptom>myopia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3842</id><symptom>onychodystrophy</symptom><category>SKIN</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2361</id><symptom>osteodystrophy / osteodystrophy, renal</symptom><category>GENITOURINARY TRACT | SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2122</id><symptom>renal cysts</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2048</id><name>Sedoheptulose-7-phosphate</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.07</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>2061</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>50.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2100</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>60.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>2101</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2102</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>GCMS</method><comment /></metabolite><metabolite><id>1978</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>160.00</min><max>590.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1979</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite></Metabolites><Literatures><literature><id>5321</id><title>Skywalker-TBC1D24 has a lipid-binding pocket mutated in epilepsy and required for synaptic function</title><author>Fischer B,</author><journal>Nat Struct Mol Biol</journal><year>2016</year><book /><volume>23</volume><number>11</number><pages>965-973</pages><co_aut>et al.</co_aut></literature><literature><id>5196</id><title>TBC1D24-Related Disorders</title><author>Mucha BE,</author><journal>GeneReviews&#174; [Internet]</journal><year>2015</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5322</id><title>Absence of Nails, Deaf-mutism, Seizures, and Intellectual Disability: A Case Report</title><author>Nair LD,</author><journal>J Clin Diagn Res</journal><year>2015</year><book /><volume>9</volume><number>4</number><pages>SD01-3</pages><co_aut>Sagayaraj B, Kumar R</co_aut></literature><literature><id>5194</id><title>The genetic basis of DOORS syndrome: an exome-sequencing study</title><author>Campeau PM,</author><journal>Lancet Neurol</journal><year>2014</year><book /><volume>13</volume><number>1</number><pages>44-58</pages><co_aut>et al.</co_aut></literature><literature><id>5323</id><title>Reduced synaptic vesicle protein degradation at lysosomes curbs TBC1D24/sky-induced neurodegeneration</title><author>Fernandes AC,</author><journal>J Cell Biol</journal><year>2014</year><book /><volume>207</volume><number>4</number><pages>453-462</pages><co_aut>et al.</co_aut></literature><literature><id>5324</id><title>DOORS syndrome: phenotype, genotype and comparison with Coffin-Siris syndrome</title><author>Campeau PM,</author><journal>Am J Med Genet C Semin Med Genet</journal><year>2014</year><book /><volume>166</volume><number>3</number><pages>327-332</pages><co_aut>et al.</co_aut></literature><literature><id>5325</id><title>Fryns syndrome without diaphragmatic hernia, DOOR syndrome or Fryns-like syndrome? Report on patients from Indian Ocean islands</title><author>Alessandri JL,</author><journal>Am J Med Genet A</journal><year>2014</year><book /><volume>164</volume><number>3</number><pages>648-654</pages><co_aut>et al.</co_aut></literature><literature><id>5326</id><title>Phenotype-genotype complexities: opening DOORS</title><author>Berkovic SF,</author><journal>Lancet Neurol</journal><year>2014</year><book /><volume>13</volume><number>1</number><pages>24-25</pages><co_aut>Gecz J</co_aut></literature><literature><id>5327</id><title>DOOR syndrome</title><author>Girish M,</author><journal>Indian Pediatr</journal><year>2011</year><book /><volume>48</volume><number>6</number><pages>479-481</pages><co_aut>Mujawar N, Salodkar A</co_aut></literature><literature><id>5195</id><title>DOOR syndrome: clinical report, literature review and discussion of natural history</title><author>James AW,</author><journal>Am J Med Genet A</journal><year>2007</year><book /><volume>143</volume><number>23</number><pages>2821-2831</pages><co_aut>et al.</co_aut></literature><literature><id>5193</id><title>[Deafness-onycho-osteodystrophy-retardation-seizures (DOORS)]</title><author>Kosuga M,</author><journal>Ryoikibetsu Shokogun Shirizu</journal><year>2001</year><book /><volume>33</volume><number>0</number><pages>537-538</pages><co_aut>Okuyama T.</co_aut></literature><literature><id>5191</id><title>DOOR syndrome: additional case and literature review</title><author>Bos CJ,</author><journal>Clin Dysmorphol</journal><year>1994</year><book /><volume>3</volume><number>1</number><pages>15-20</pages><co_aut>et al.</co_aut></literature><literature><id>5192</id><title>Congenital sensori-neural deafness associated with onycho-osteo dystrophy and mental retardation (D.O.O.R. syndrome)</title><author>Cantwell RJ</author><journal>Humangenetik</journal><year>1975</year><book /><volume>26</volume><number>3</number><pages>261-265</pages><co_aut /></literature></Literatures></Disease>